YU58699A - - Google Patents

Info

Publication number
YU58699A
YU58699A YU58699A YU58699A YU58699A YU 58699 A YU58699 A YU 58699A YU 58699 A YU58699 A YU 58699A YU 58699 A YU58699 A YU 58699A YU 58699 A YU58699 A YU 58699A
Authority
YU
Yugoslavia
Application number
YU58699A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21959336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU58699(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of YU58699A publication Critical patent/YU58699A/xx
Publication of RS49675B publication Critical patent/RS49675B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YUP-586/99A 1997-06-11 1998-05-29 4"supstituisani-9-deokso-9a-aza-9a- homoeritromicin a derivati RS49675B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934897P 1997-06-11 1997-06-11
PCT/IB1998/000839 WO1998056802A1 (en) 1997-06-11 1998-05-29 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives

Publications (2)

Publication Number Publication Date
YU58699A true YU58699A (https=) 2002-08-12
RS49675B RS49675B (sr) 2007-11-15

Family

ID=21959336

Country Status (49)

Country Link
US (4) US6420536B1 (https=)
EP (1) EP0988310B9 (https=)
JP (2) JP3315704B2 (https=)
KR (1) KR100396168B1 (https=)
CN (4) CN1793155B (https=)
AP (1) AP1231A (https=)
AR (1) AR013086A1 (https=)
AT (1) ATE251173T1 (https=)
AU (1) AU749816B2 (https=)
BG (1) BG64391B1 (https=)
BR (1) BRPI9810519B8 (https=)
CA (1) CA2293823C (https=)
CO (1) CO4950611A1 (https=)
CZ (1) CZ298556B6 (https=)
DE (2) DE122004000018I2 (https=)
DK (1) DK0988310T3 (https=)
DZ (1) DZ2514A1 (https=)
EA (1) EA002441B1 (https=)
EG (1) EG24081A (https=)
ES (1) ES2205487T3 (https=)
FR (1) FR04C0013I2 (https=)
GT (1) GT199800077A (https=)
HN (1) HN1998000086A (https=)
HR (1) HRP980314B1 (https=)
HU (2) HU228005B1 (https=)
ID (1) ID22992A (https=)
IL (1) IL132809A0 (https=)
IS (1) IS1998B (https=)
LU (1) LU91076I9 (https=)
MA (1) MA24564A1 (https=)
ME (1) ME00876B (https=)
MY (1) MY123354A (https=)
NL (1) NL300150I2 (https=)
NO (1) NO316911B1 (https=)
NZ (2) NZ500660A (https=)
OA (1) OA11224A (https=)
PA (1) PA8452201A1 (https=)
PE (1) PE79699A1 (https=)
PL (1) PL191601B1 (https=)
PT (1) PT988310E (https=)
RS (1) RS49675B (https=)
SI (1) SI0988310T1 (https=)
SK (1) SK284171B9 (https=)
TN (1) TNSN98082A1 (https=)
TW (1) TW472060B (https=)
UA (1) UA67744C2 (https=)
UY (1) UY25040A1 (https=)
WO (1) WO1998056802A1 (https=)
ZA (1) ZA985017B (https=)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
ES2281136T3 (es) * 1997-09-10 2007-09-16 Merial Ltd. Uso de 9a-azalidos como agentes antimicrobiales veterinarios.
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
DE60038610T2 (de) * 1999-05-18 2009-06-25 Pfizer Products Inc., Groton Neue kristalline formen eines makrolidantibiotikums
HUP0201516A3 (en) * 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
DK1206476T3 (da) * 1999-08-24 2006-05-15 Abbott Lab 9a-azalider med antibakteriel virkning
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
BRPI0017013B1 (pt) 2000-01-27 2015-07-14 Zoetis P Llc Composição de antibiótico azalídeo e método para sua obtenção
BR0110382A (pt) * 2000-04-27 2003-06-24 Pfizer Prod Inc Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
RU2263117C2 (ru) * 2001-04-27 2005-10-27 Пфайзер Продактс Инк. Способ получения 4"-замещенных производных 9-деоксо-9а-аза-9а-гомоэритромицина а
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
MXPA06005639A (es) * 2003-11-21 2006-08-17 Pfizer Prod Inc Adyuvante antimicrobiano.
CN103030617A (zh) * 2004-03-16 2013-04-10 贝林格尔.英格海姆国际有限公司 吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
ATE429921T1 (de) * 2005-01-14 2009-05-15 Glaxosmithkline Zagreb 9a-carbamoyl- und thiocarbamoylazalide mit antimalariawirkung
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) * 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
WO2012038372A1 (en) 2010-09-20 2012-03-29 Novartis Ag Novel process for the preparation of 9-deoxo-9a-aza- 9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group
EP2625185A4 (en) * 2010-10-10 2014-03-26 Synovo Gmbh INFLAMMATORY MAKROLIDE
WO2013004116A1 (zh) * 2011-07-06 2013-01-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
EP3027634B1 (en) * 2013-07-31 2018-03-21 Farma GRS, d.o.o. Process for preparation of tulathromycin
CN103497227B (zh) * 2013-09-13 2015-09-30 青岛科技大学 一种泰拉菌素中间体的制备方法
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
CN104861018A (zh) * 2015-06-17 2015-08-26 瑞普（天津）生物药业有限公司 一种泰拉菌素的制备方法
CN105646617A (zh) * 2016-01-21 2016-06-08 杭州海尔希畜牧科技有限公司 一种制备泰拉霉素的方法
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
CN106046077B (zh) * 2016-08-04 2019-07-26 湖北美天生物科技股份有限公司 一种泰拉霉素a的合成方法
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
CN111087433B (zh) * 2018-10-23 2023-03-21 湖北美天生物科技股份有限公司 一种泰拉霉素中间体的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5226958A (en) * 1991-04-11 1993-07-13 Pacemark, Inc. Sealant for pneumatic inner tubes and tubeless tires
EP0549040A1 (en) 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
CN1793155A (zh) 2006-06-28
RS49675B (sr) 2007-11-15
US20040180842A1 (en) 2004-09-16
CN1566129A (zh) 2005-01-19
CZ442199A3 (cs) 2000-07-12
HUS1200028I1 (hu) 2016-08-29
KR100396168B1 (ko) 2003-08-27
PL337505A1 (en) 2000-08-28
DZ2514A1 (fr) 2003-02-01
DK0988310T3 (da) 2003-12-15
AP1231A (en) 2003-12-11
US6777393B2 (en) 2004-08-17
HK1028048A1 (en) 2001-02-02
TNSN98082A1 (fr) 2005-03-15
CN1243766C (zh) 2006-03-01
HUP0002209A2 (hu) 2000-12-28
PL191601B1 (pl) 2006-06-30
US6420536B1 (en) 2002-07-16
NO996106L (no) 2000-02-10
DE69818665T2 (de) 2004-04-29
HK1068893A1 (en) 2005-07-29
EA199901015A1 (ru) 2000-06-26
EP0988310B1 (en) 2003-10-01
HK1088014A1 (zh) 2006-10-27
PA8452201A1 (es) 2000-05-24
ATE251173T1 (de) 2003-10-15
AU749816B2 (en) 2002-07-04
AR013086A1 (es) 2000-12-13
EP0988310B9 (en) 2006-03-08
BG64391B1 (bg) 2004-12-30
PE79699A1 (es) 1999-08-25
BRPI9810519B1 (pt) 2012-02-22
NZ500660A (en) 2002-03-01
SI0988310T1 (en) 2004-02-29
UA67744C2 (uk) 2004-07-15
BG103945A (bg) 2000-07-31
CZ298556B6 (cs) 2007-11-07
WO1998056802A1 (en) 1998-12-17
JP2000514098A (ja) 2000-10-24
AU7347598A (en) 1998-12-30
DE69818665D1 (de) 2003-11-06
HRP980314A2 (en) 1999-04-30
BRPI9810519B8 (pt) 2022-11-16
IS1998B (is) 2005-03-15
ZA985017B (en) 1999-12-17
CN101691390A (zh) 2010-04-07
LU91076I2 (fr) 2004-07-05
ME00876B (me) 2012-06-20
CN1172947C (zh) 2004-10-27
BRPI9810519A (pt) 2000-09-19
HN1998000086A (es) 1999-03-08
ES2205487T3 (es) 2004-05-01
NL300150I1 (nl) 2004-08-02
EP0988310A1 (en) 2000-03-29
GT199800077A (es) 1999-12-02
ID22992A (id) 1999-12-23
MY123354A (en) 2006-05-31
JP2002316933A (ja) 2002-10-31
CO4950611A1 (es) 2000-09-01
NO316911B1 (no) 2004-06-21
EA002441B1 (ru) 2002-04-25
JP3315704B2 (ja) 2002-08-19
NL300150I2 (nl) 2004-09-01
DE122004000018I1 (de) 2004-09-30
CN1793155B (zh) 2010-05-12
AP9801255A0 (en) 1998-06-30
SK284171B9 (sk) 2005-03-04
NZ514871A (en) 2003-08-29
IL132809A0 (en) 2001-03-19
HRP980314B1 (en) 2004-04-30
TW472060B (en) 2002-01-11
KR20010013632A (ko) 2001-02-26
UY25040A1 (es) 2000-09-29
HU228005B1 (en) 2012-08-28
MA24564A1 (fr) 1998-12-31
CA2293823A1 (en) 1998-12-17
US6936592B2 (en) 2005-08-30
US20020061858A1 (en) 2002-05-23
SK168399A3 (en) 2000-11-07
CN1259136A (zh) 2000-07-05
EG24081A (en) 2008-05-11
OA11224A (en) 2003-07-16
IS5252A (is) 1999-11-16
SK284171B6 (sk) 2004-10-05
HUP0002209A3 (en) 2003-05-28
FR04C0013I1 (https=) 2004-06-11
DE122004000018I2 (de) 2011-01-13
NO996106D0 (no) 1999-12-10
US20040023896A1 (en) 2004-02-05
LU91076I9 (en) 2018-07-02
PT988310E (pt) 2003-12-31
CA2293823C (en) 2004-02-17
FR04C0013I2 (https=) 2005-10-21

Similar Documents

Publication Publication Date Title
BE2018C032I2 (https=)
CH0944937H2 (https=)
IN184740B (https=)
BR9700653A (https=)
BR9701757A (https=)
CN3055036S (https=)
CN3054602S (https=)
CN3052972S (https=)
CN3053002S (https=)
CN3053170S (https=)
CN3053248S (https=)
CN3053500S (https=)
CN3055603S (https=)
CN3053525S (https=)
CN3053852S (https=)
CN3053995S (https=)
CN3054099S (https=)
CN3054162S (https=)
CN3055290S (https=)
CN3054556S (https=)
CN3055233S (https=)
CN3054752S (https=)
CN3054753S (https=)
CN3054902S (https=)
CN3056021S (https=)